Tag: TransGender

FDA, acknowledge that Hormone Treatment during Pregnancy can cause InterSex and TransGender!

Petitioning The US Food and Drug Administration

change logo
FDA, acknowledge that hormone treatment during pregnancy can cause intersex and transgender!

This petition is to ask the FDA to acknowledge that, when a pregnant woman is given medical treatment with synthetic hormones, these substances can cross the placenta and cause abnormalities of sexual development in her unborn child, including both physical intersex conditions and transgender.

There are a variety of situations in which medical treatments involving high doses of synthetic hormones are given to pregnant women. Many of these treatments would, if given in the same dose to an adult man, suppress his testosterone production and have other feminising effects on him. Based on my own experiences and what I’ve seen of the effects of an artificial estrogen called DES, they can do the same thing to a male foetus, the main difference being that the effects are permanent. Due to the way foetal development takes place and the fact that most medical use of these drugs tends to be during the second half of the pregnancy, brain development is more likely to be affected than physical development.

Read Hugh Easton own story and SIGN the petition.

More DES DiEthylStilbestrol Resources

Effect of DiEthylStilboestrol on Gonad Development

Gonadal feminization and feminization of the quail following DES exposure

1st Abstract – 1979

image of PubMed NCBI The Endocrine Society logo
The effect of diethylstilboestrol on gonad development in quail embryos has been quantitatively analysed.

Early treatment of Quail eggs by DES promotes a transient feminization of the gonads in genetic males and a strong stimulation of the Müllerian ducts. The left ovotestis results from the juxtaposition of a testicular medulla and an induced female-type cortex, which develops follicles and a characteristic 17 beta-HSD activity. The right testis is reduced but keeps a consistent structure. The medulla of the treated gonads shows, in both sexes, an inhibition of delta 5-3 beta HSD activity during embryonic development. After hatching, this specific enzyme then develops in the steroidogenic cells. These results are compared with others obtained with estradiol and also in chick. The discussion deals also with the effects of these estrogens on the endogenous abilities and specific responses of the gonads in relation to sex differentiation factors.

2nd Abstract – 1995

The effect of diethylstilboestrol on gonad development in quail embryos has been quantitatively analysed. Quail embryos at 4 days of incubation were treated with diethylstilboestrol (DES), using the egg dipping method. At 10 days of incubation, embryos were removed and killed by decapitation. Tissues were prepared for chromosome analysis, and the parts of the abdomen containing the gonads were prepared for serial sectioning and quantitative assessment. Left gonads of DES-treated male embryos resembled ovaries histologically, while their right gonads were markedly reduced in size. Right gonads of DES-treated female embryos were also further reduced by treatment with DES. There was no statistically significant effect by DES treatment on the size of left gonads, although the ratio of left compared with right gonadal volumes was highly significant. Since, in birds, the left embryonic gonad has ambisexual potential, while the potential of the right gonad is exclusively masculine, these results exemplify the adverse effect exerted by oestrogen on male sexual development in vertebrates.

Sources
  • Feminization of the quail by early diethylstilbestrol treatment: histoenzymological investigations on steroid dehydrogenases in the gonads, NCBI, PMID: 294849, 1979;68(2):85-98.
  • A quantitative investigation of gonadal feminization by diethylstilboestrol of genetically male embryos of the quail Coturnix coturnix japonica, NCBI, PMID: 7616493, 1995 Mar;103(2):223-6.
  • Full text: Journal of Reproduction and Fertility, doi: 10.1530/jrf.0.1030223
More DES DiEthylStilbestrol Resources

How could a seemingly Healthy Boy grow up with the Feelings of a Little Girl?

Did something just happen last week or was it at a young age? Was it a curse from God or a side effect from modern medicine?

little angel image
Laura Amato’s mother was immediately placed on DES when she became pregnant again.

” So, how could this all happen? How could a seemingly healthy boy grow up with the feelings of a little girl? Did something just happen last week or was it at a young age? Was it from abuse and cruelty or from circumstances that just happened? Was it a curse from God or a side effect from modern medicine? Can This be prevented from happening to some other boy? Hopefully this Biography can answer some of your questions and maybe some of mine as well.

Before my mother had her first child she suffered three miscarriages. Modern medicine at that time was just starting to study hormonal effects in childbirth. It was discovered that my mother’s hormone levels were deficient in Estrogen after conception. Scientists introduced a new drug called DES which was designed to improve these levels. So when my mother became pregnant with me she was immediately placed on DES… ”

Continue reading Laura Amato Transsexual Biography, Parts 1 and 2, Laura’sPlayground.com

More information

The Link between DES Exposure and MTF Transsexuality

DES is probably the unacknowledged cause of most cases of MTF transsexuality among those born prior to the mid-1970s. Does Dr. Keith Ablow knows?

What if DES was the unacknowledged cause of most cases of MTF transsexuality among those born prior to the mid-1970s…

Brynn Tannehill
Brynn Tannehill is parent, writer, scientist, and advocate for trans inclusion in the military.

In January 2014, Dr. Keith Ablow, psychiatrist and member of the Fox News Medical A-Team, dismissed any biological origins of gender dysphoria, stating he was “Not convinced’ being TransGender exists“…

Few day later, Brynn Tannehill, Director of Advocacy, SPART*A, published a paper with no less than 15 studies showing a biological origin of gender dysphoria… One of them is a mention about DES:
“In this study, more than 150 individuals with confirmed or suspected prenatal diethylstilbestrol (DES) exposure reported moderate to severe feelings of gender dysphoria across the lifespan.”

More information

Prenatal DiEthylStilbestrol Exposure in Males and Gender-related Disorders

PRENATAL EXPOSURE TO DIETHYLSTILBESTROL (DES) IN MALES AND GENDER-RELATED DISORDERS: RESULTS FROM A 5-YEAR STUDY

Abstract

PRENATAL EXPOSURE TO DIETHYLSTILBESTROL (DES) IN MALES AND GENDER-RELATED DISORDERS: RESULTS FROM A 5-YEAR STUDY
Important research on DES exposure in males.

For many years, researchers and public health specialists have been assessing the human health impact of prenatal exposure to the estrogenic anti-miscarriage drug, diethylstilbestrol (commonly known as DES or “stilbestrol”). The scope of adverse effects in females exposed to DES (often called “DES daughters“) has been more substantially documented than the effects in males (“DES sons“). This paper contributes three areas of important research on DES exposure in males:

  1. an overview of published literature discussing the confirmed and suspected adverse effects of prenatal exposure in DES sons;
  2. preliminary results from a 5-year online study of DES sons involving 500 individuals with confirmed (60% of sample) and suspected prenatal DES exposure;
  3. documentation of the presence of gender identity disorders and male-to-female transsexualism reported by more than 100 participants in the study.

Read the Full Paper prepared for the International Behavioral Development Symposium 2005, PRENATAL EXPOSURE TO DIETHYLSTILBESTROL (DES) IN MALES AND GENDER-RELATED DISORDERS: RESULTS FROM A 5-YEAR STUDY, by Scott P. Kerlin, Ph.D., DES Sons International Network, Aug 2005.

More DES DiEthylStilbestrol Resources

Gender-related Behavior in Women exposed prenatally to DiEthylStilbestrol

The physical and psychological impact of the problems associated with DES exposure are well documented

1993 Study Abstract

Gender-related behavior in women exposed prenatally to diethylstilbestrol
The physical and psychological impact of the problems associated with exposure to DES are well documented

Accumulating evidence in experimental animals over the past three decades suggests that mammalian brain development and differentiation of the central nervous system are influenced by perinatal exposure to sex hormones. Hence, changes in human behavioral patterns may be associated with prenatal exposure to estrogenic substances such as diethylstilbestrol (DES). This paper reviews relevant studies from a series of laboratories and finds that no clear-cut differences can be demonstrated to date between unexposed and DES-exposed women in gender-related behavior, although the physical and psychological impact of the problems associated with exposure to DES are well documented. If both prenatal and postnatal influences such as social, economic, and environmental factors are taken into consideration, individual variation is more apparent than differences in gender-related behavior between unexposed and DES-exposed women. In summary, gender-related behavior is determined by a complex array of interacting factors, and prenatal influences are only one of many developmental events. More studies are needed using larger populations with carefully controlled selection criteria to suggest a direct role of prenatal DES exposure on subsequent gender-related behavior.

Sources: Gender-related Behavior in Women exposed prenatally to DiEthylStilbestrol
Dr R Hoover, NCBI, Aug 1993 – full study PDF

More DES DiEthylStilbestrol Resources

My Transsexual Summer

Follow seven people’s journeys to realise their true identities

my-transsexual-summer-foxDid you know that there is significant evidence linking prenatal exposure to estrogens with gender identity and transsexual development

Watch My Transsexual Summer on Channel4.

More information